Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the
VEGF‐A
/caveolin‐1/
PV
‐1 signaling pathway
Keyword(s):
2016 ◽
Vol 34
(5)
◽
pp. 308-313
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 18
(10)
◽
pp. 783-791
◽
Keyword(s):
2012 ◽
Vol 227
(6)
◽
pp. 2480-2491
◽
Keyword(s):